Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Yenimahalle
Clinical trial register · Turkey

Clinical Trials in Yenimahalle, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Turkey and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5418 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:18 UTC
5418
Studies in scope
all four open statuses
2461
Recruiting now
open to new participants
548
Lead sponsors
across recruiting studies
Top sites
Istanbul 1988 Ankara 1440 Izmir 568 Adana 377 Antalya 261
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AbbVie5 Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital5 AstraZeneca5 Ankara Etlik City Hospital4 Atatürk Chest Diseases and Chest Surgery Training and Research Hospital4
Site location
Istanbul1988 Ankara1440 Izmir568 Adana377 Antalya261
All 318 locations
Target enrolment
to

Trials with a site in Yenimahalle

61 of 5418 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Turkey
Start
Recruiting
Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
Observational
170
Yenimahalle
2026-10-02
Not yet open
Azafaros B.V.
Phase 2
20
Bornova, Yenimahalle
2026-09-28
Recruiting
Intrathecal Morphine and Transversalis Fascia Plane Block for Analgesia After Open Inguinal Hernia Repair
NCT07826741Pain, Postoperative, Inguinal Hernia Unilateral, Intrathecal Morphine, Transversalis Fascia Plane Block
Atatürk Chest Diseases and Chest Surgery Training and Research Hospital
Not applicable
90
Yenimahalle
2026-09-18
Recruiting
One-level and Bi-level ESPB Application in Patients Undergoing Breast Surgery
NCT07747623Pain, Postoperative, Breast Surgery, Erector Spinae Plane Block, Multimodal Analgesia
Atatürk Chest Diseases and Chest Surgery Training and Research Hospital
Not applicable
70
Yenimahalle
2026-09-11
Recruiting
Vividion Therapeutics, Inc.
Phase 2
140
Bilkent Çankaya, Kadıköy, Edirne, Gaziantep, Istanbul, Samsun, Yenimahalle
2026-09-11
Not yet open
Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
Observational
70
Yenimahalle
2026-09-01
Recruiting
Anterior Suprascapular and Axillary vs. Interscalene Block for Analgesia and Diaphragmatic Function in Shoulder Surgery
NCT07739303Peripheral Nerve Block, Pain Management, Diaphragm Protective Block, Upper Extremity
Ankara Etlik City Hospital
Not applicable
70
Yenimahalle
2026-08-06
Recruiting
Mechanical Power During Different Ventilation Modes in Laparoscopic Surgery
NCT07670494Laparoscopic Cholecystectomy, Mechanical Ventilation, Ventilator-Induced Lung Injury
Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
Not applicable
80
Yenimahalle
2026-07-01
Recruiting
Effect of Bilateral Maxillary Block on Intraoperative Remifentanil Consumption
NCT07608861Septorhinoplasty, Remifentanil Consumption, Maxillary Block
Atatürk Chest Diseases and Chest Surgery Training and Research Hospital
Not applicable
80
Yenimahalle
2026-06-01
Recruiting
Jiangsu HengRui Medicine Co., Ltd.
Phase 3
150
Mamak, Fatih, Kadıköy, Pendik, Izmir, Kınıklı, Sakarya, Yenimahalle
2026-04-16
Recruiting
Can Ultrasound-Guided Fascial Plane Blocks Reduce Postoperative Pulmonary Complications After Major Abdominal Surgery?
NCT07394816Postoperative Pulmonary Complications (PPCs), Abdominal Surgeries, Postoperative Pain Management
Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
Observational
500
Yenimahalle
2026-03-01
Recruiting
Comparative Analgesia and Respiratory Effects of Shoulder Blocks
NCT07429669Postoperative Pain, Arthroscopic Shoulder Surgery
Atatürk Chest Diseases and Chest Surgery Training and Research Hospital
Not applicable
120
Yenimahalle
2026-02-23
Recruiting
Malnutrition Screening Study
NCT07256925Malnutrition, Calorie, Sarcopenia
Abbott Nutrition
Observational
7,500
Sarıçam, Altındağ, Çankaya, Yenimahalle, Kepez, Konyaalti, Muratpaşa, Nilufer
2026-01-12
Active, closed
Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
Observational
150
Yenimahalle
2026-01-01
Recruiting
Comparison of Conventional and Retroclavicular Approaches for Ultrasound-guided Infraclavicular Brachial Plexus Block
NCT07151443Peripheral Nerve Block, Pain Management, Forearm Surgery, Hand Surgery
Ankara Etlik City Hospital
Not applicable
60
Yenimahalle
2025-09-15
Not yet open
Different Intraperitoneal Pressures on Optic Nerve Sheath Diameter in Laparoscopic Surgeries
NCT07155109Intracranial Pressure Increase, Abdominal Pain, Head Pain
Diskapi Yildirim Beyazit Education and Research Hospital
Not applicable
100
Yenimahalle
2025-08-30
Not yet open
Comparison of Gastric Volume in I-gel and ProSeal Laryngeal Mask Airways
NCT07138092Nausea and Vomiting, Postoperative, Sore-throat
Diskapi Yildirim Beyazit Education and Research Hospital
Not applicable
50
Yenimahalle
2025-08-18
Not yet open
Air-Q in Totally Edentulous and Dentate Geriatric Patients
NCT07138079Postoperative Complications, Sore-throat
Diskapi Yildirim Beyazit Education and Research Hospital
Not applicable
50
Yenimahalle
2025-08-18
Recruiting
Kedrion S.p.A.
Phase 3
40
Ankara, Yenimahalle, Edirne, Izmir, Mersin, Adapazarı
2025-08-13
Not yet open
The Effect of Dexmedetomidine on Postoperative Cognitive Function in Geriatric Patients
NCT07047898Dexmedetomidine, Robotic Surgery, Geriatric Patients
Ankara Etlik City Hospital
Not applicable
60
Yenimahalle
2025-08
Recruiting
Comparison of Postoperative Analgesic Efficacy of Transversus Abdominis Plane Block (TAP) and Modified Thoracoabdominal Nerve Block (M-TAPA)
NCT06932835Laparoskopic Cholecystectomy, Transversus Abdominis Plane (TAP) Block, Modified Thoracoabdominal Nerve Block (M-TAPA)
Ankara Etlik City Hospital
Not applicable
80
Yenimahalle
2025-06-02
Active, closed
AstraZeneca
Phase 3
3,103
Adana, Afyonkarahisar, Ankara, Eskişehir, Izmir, Kocaeli, Odunpazari, Yenimahalle
2025-05-28
Recruiting
CorMedix Therapeutics
Phase 3
200
Altındağ, Çankaya, Yenimahalle, Istanbul
2025-05-14
Not yet open
Diskapi Yildirim Beyazit Education and Research Hospital
Observational
100
Yenimahalle
2024-11-20
Recruiting
AstraZeneca
Phase 3
1,160
Ankara, Antalya, Istanbul, Yenimahalle
2024-11-18
Active, closed
Merck Sharp & Dohme LLC
Phase 1/2
180
Yenimahalle, Balçova, Adana, Ankara
2024-11-03
By invitation
UCB Biopharma SRL
Phase 3
12
Yenimahalle
2024-10-08
Active, closed
Pharmacokinetic Similarity Between ABP 234 and Keytruda® (Pembrolizumab)
NCT06430866Early-stage Non-squamous Non-small Cell Lung Cancer (NSCLC)
DrugsABP 234·Pembrolizumab
Amgen
Phase 3
163
Yenimahalle, İskender, Adana, Ankara, Bursa, Gaziantep, Istanbul, Sakarya
2024-09-12
Active, closed
Amgen
Phase 3
315
Seyhan, Keçiören, Yenimahalle, İskender, Atakum, Adana, Ankara, Bursa
2024-09-09
Recruiting
Bayer
Phase 3
555
Bilkent Çankaya, Kadıköy, Istanbul, Izmir, Küçükçekmece, Sakarya, Yenimahalle, Yüreğir
2024-08-28
Active, closed
UCB Biopharma SRL
Phase 2/3
14
Yenimahalle
2024-06-14
Active, closed
AstraZeneca
Phase 2
76
Ankara, Yenimahalle
2024-04-21
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,200
Yenimahalle, Stanbul, Adana, Ankara, Istanbul, Samsun
2024-04-14
Recruiting
Arch Biopartners Inc.
Phase 2
240
Yenimahalle, Kartal, Melikgazi, İzmit, Kahramanmaraş
2024-03-08
Active, closed
Cynata Therapeutics Limited
Phase 2
60
Eskişehir, Istanbul, Izmir, Malatya, Yenimahalle
2024-03-04
Recruiting
Regeneron Pharmaceuticals
Phase 3
580
Mamak, Yenimahalle, Ankara, Mezitli, Tekirdağ, Istanbul, Izmir, Sakarya
2023-12-28
Active, closed
Bristol-Myers Squibb
Phase 3
190
Yenimahalle, Adana, Ankara, Istanbul, Sakarya
2023-12-21
Recruiting
AstraZeneca
Phase 3
1,145
Ankara, Antalya, Cordaleo, Eskişehir, Istanbul, Yenimahalle
2023-12-14
Recruiting
Regeneron Pharmaceuticals
Phase 3
904
Yenimahalle, Mezitli, Tekirdağ, Ankara, Istanbul, Izmir, Sakarya, Samsun
2023-12-13
Recruiting
Regeneron Pharmaceuticals
Phase 3
822
Mamak, Yenimahalle, Ankara, Mezitli, Tekirdağ, Istanbul, Izmir, Kayseri
2023-12-12
Recruiting
Akero Therapeutics, Inc
Phase 3
1,650
Yenimahalle, Bornova, Bursa, Rize
2023-12-01
Active, closed
AbbVie
Phase 3
289
Yenimahalle, Dilovası, Ankara, Antalya, Izmir, Mersin
2023-11-15
Active, closed
Regeneron Pharmaceuticals
Phase 3
733
Mamak, Yenimahalle, Ankara, Mezitli, Sakarya, Tekirdağ, Istanbul, Kayseri
2023-11-14
Active, closed
Akero Therapeutics, Inc
Phase 3
700
Yenimahalle, Bornova, Bursa, Rize
2023-11-10
Recruiting
Acrotech Biopharma Inc.
Phase 3
504
Altındağ, Çankaya, Yenimahalle, Şişli, Adana, Bornova
2023-10-04
Active, closed
Bristol-Myers Squibb
Phase 3
774
Yenimahalle, Ankara, Antalya, Istanbul
2023-09-11
Recruiting
AstraZeneca
Phase 3
231
Bursa, Istanbul, Izmir, Yenimahalle
2023-08-24
Active, closed
AbbVie
Phase 3
1,014
Sihhiye, Ankara, Yenimahalle, Şehitkamil, Antalya, Istanbul, Meram Konya, Trabzon
2023-07-25
Active, closed
Bristol-Myers Squibb
Phase 3
1,230
Ankara, Çankaya, Edirne, Istanbul, Izmir, Kayseri, Yenimahalle
2023-06-22
Active, closed
Study of Novel Treatment Combinations in Patients With Lung Cancer
NCT05633667Lung Cancer, Advanced or Metastatic Non-Small-Cell Lung Cancer, Resectable Non-Small-Cell Lung Cancer
DrugsDomvanalimab·Zimberelimab·Sacituzumab Govitecan·Nab-paclitaxel
Gilead Sciences
Phase 2
192
Adana, Ankara, Atakum, Diyarbakır, Konya, Meram Konya, Yenimahalle
2023-03-16
Active, closed
Incyte Corporation
Phase 3
82
Ankara, Center, Istanbul, Izmir, Kayseri, Mersin, Yenimahalle
2022-12-23
Active, closed
Celgene
Phase 3
939
Kavaklıdere, Yenimahalle, Pendik, Balçova, Bornova, Samsun, Ankara, Gaziantep
2022-06-23
Active, closed
Protagonist Therapeutics, Inc.
Phase 3
293
Balkiraz, Yenimahalle, Pamukkale, Bornova, Trabzon, Gaziantep, Istanbul, Kayseri
2022-04-01
Recruiting
Merck Sharp & Dohme LLC
Phase 2/3
290
Yenimahalle, Bornova, Ankara, Istanbul, Izmir, Samsun
2022-01-14
Active, closed
Jazz Pharmaceuticals
Phase 3
920
Ankara, Edirne, Izmir, Seyhan, Trabzon, Yenimahalle
2021-12-02
Active, closed
Gilead Sciences
Phase 3
603
Ankara, Bursa, Dikimevi- Ankara, Edirne, Istanbul, Kadıköy, Sariyer, Yenimahalle
2021-11-17
Active, closed
AbbVie
Phase 3
527
Yenimahalle, Ankara, Istanbul, Mersin
2020-09-30
Active, closed
Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies (KL264-01)
NCT04152499Epithelial Ovarian Cancer, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Urothelial Carcinoma
DrugSacituzumab tirumotecan
Klus Pharma Inc.
Phase 1/2
1,410
Yenimahalle
2020-02-28
By invitation
International Registry of Congenital Portosystemic Shunt (IRCPSS)
NCT06041906Congenital Portosystemic Shunt, CPSS (Congenital Portosystemic Shunt)
Prof. Valérie Mc Lin
Observational
500
Yenimahalle
2018-04-26
Active, closed
AbbVie
Phase 3
747
Yenimahalle, Kadıköy, Şişli, Melikgazi, Ankara, Battalgazi/malatya, Hatay, Istanbul
2018-03-21
Active, closed
AbbVie
Phase 3
950
Yenimahalle, Melikgazi, Cerrahpaşa, Istanbul, Mersin
2017-01-31
Rows per page Showing 1–61 of 61
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Turkish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 October 2026. https://priyalifescience.com/clinical-trials-turkey/city/yenimahalle

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Turkey and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,418 studies in total at the last sync on 11 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 61 of those studies with a site in Yenimahalle.

How many clinical trials are recruiting in Yenimahalle?

27 of the 61 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:18 UTC sync. A further 7 have not yet opened recruitment, 25 are active but closed to new participants, and 2 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Yenimahalle), 61 studies
PhaseStudiesRecruitingShare
Phase 3321352.5%
Not applicable12819.7%
Observational7311.5%
Phase 2629.8%
Phase 1/2203.3%
Phase 2/3213.3%

Most active sponsors

Lead sponsors with the most studies (Yenimahalle)
Lead sponsorStudiesRecruiting
AbbVie50
AstraZeneca53
Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital53
Ankara Etlik City Hospital43
Atatürk Chest Diseases and Chest Surgery Training and Research Hospital44
Diskapi Yildirim Beyazit Education and Research Hospital40
Regeneron Pharmaceuticals43
Bristol-Myers Squibb30
Merck Sharp & Dohme LLC32
Akero Therapeutics, Inc21
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.